Global Cell-Based Assay Market to Generate $26.34 Billion by 2030: Allied Market Research

According to the report published by Allied Market Research, the global Cell-Based Assay Market generated $11.74 billion in 2020, and is expected to generate $26.34 billion by 2030, witnessing a CAGR of 8.2% from 2021 to 2030. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.

For Right Perspective, Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/4425

Increase in demand for cell-based assays in drug discovery, huge investments in cell-based research, and rise in the number of drug discovery companies drive the growth of the global cell-based assay market. However, high costs of tests and scarcity of competent professionals restrain the market growth. On the other hand, increase in the usage of cell-based assay techniques for high throughput screening methods such as toxicity studies, drug screening, in-vitro testing, and others creates new opportunities in the coming years.

Based on product, the consumables segment held the highest share in 2020, accounting for more than half of the total share, and is expected to continue its leadership status during the forecast period. However, the services segment is expected to manifest the highest CAGR of 11.0% from 2021 to 2030.

Based on end user, the pharmaceutical & biotechnology companies segment contributed to the highest share in 2020, accounting for nearly half of the total share of the global cell-based assay market, and is projected to continue its lead position during the forecast period. However, the academic & government institutions segment is estimated to witness the fastest CAGR of 10.1% from 2021 to 2030.

Based on region, North America held the highest share in 2020, accounting for more than two-fifths of the total market share, and is expected to continue its dominance in terms of revenue by 2030. However, Asia-Pacific is estimated to portray the largest CAGR of 10.6% during the forecast period.

Leading players of the global cell-based assay market analyzed in the research include Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Merck KGaA, General Electric Company, Bio-Rad Laboratories, Inc., Perkinelmer, Inc., Cell Signaling Technology, Inc., Lonza Group Ltd., and Promega Corporation.

Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/4425

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of 'Market Research Reports' and 'Business Intelligence Solutions'. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.